C40.0 Malignant neoplasm of scapula and long bones of upper limb

⚠ Non-Billable ICD-10-CM 2026
Open C40.0 in the app →

Get what a quick lookup can't: the AI assistant for official-guideline questions, HCC risk-adjustment mappings (CMS-HCC V24/V28, RxHCC), FDA drug indications, and AHA Coding Clinic references for C40.0.

The ICD-10-CM code for Malignant neoplasm of scapula and long bones of upper limb is C40.0 (FY2026). It is a non-billable category code — select a more specific code below for claims.

Classification

Section
C40-C41: Malignant neoplasms of bone and articular cartilage (C40-C41)
Category C40
25 codes (18 billable)
FY2026 Status
Stable since FY2024

Also Known As

ICD-10-CM Alphabetic Index entries that lead to C40.0:

  • Ameloblastoma › long bones › upper limb
  • Adamantinoma › long bones › upper limb

Official Coding Guidelines

Tx of primary site (TOC entry)

a. Admission/Encounter for treatment of primary site ............................................................. 33

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.2.a
Tx of secondary site (TOC entry)

b. Admission/Encounter for treatment of secondary site .......................................................... 33

— ICD-10-CM Official Guidelines for Coding and Reporting, FY2026, Section I.C.2.b

Source: CMS — ICD-10-CM Official Guidelines for Coding and Reporting, FY2026

References

Cite This Page

Reference C40.0 with the canonical source and edition:

C40.0 — Malignant neoplasm of scapula and long bones of upper limb. ICD-10 Coding Pro (ICD-10-CM FY2026). https://icd10codingpro.com/codes/C40.0

Canonical URL: https://icd10codingpro.com/codes/C40.0

Related Codes

Parent Code

C40 Malignant neoplasm of bone and articular cartilage of limbs

More Specific Codes

Related Codes in C40

Search all 70,000+ ICD-10-CM codes →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2025-10-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial